血糖値モニタリング

Diabetes is a chronic health condition that affects how the body regulates blood sugar, its primary source of energy. Normally, the hormone insulin helps glucose enter cells for energy, but in diabetes, the body either does not produce enough insulin or cannot use it effectively. This leads to elevated blood sugar levels, which, if left untreated, can cause serious health complications or even death.

Continuous glucose monitoring (CGM) revolutionizes diabetes management by providing real-time glucose readings without frequent finger-pricks. Wearable CGM devices use a sensor under the skin to measure glucose in interstitial fluid, transmitting data to smartphones, receivers, or cloud platforms. This data aids treatment decisions, enhances glycemic control, and enables remote monitoring. With rising diabetes rates, CGMs are vital for managing both Type 1 and Type 2 diabetes.

A CGM system's core is an electrochemical sensor with electrodes. Glucose oxidation generates tiny currents, measured and processed by a specialized analog front end (AFE). The AFE converts sensor currents into digital data with high accuracy and ultra-low power consumption. Modern AFEs handle multi-electrode configurations, bias control, and diagnostics for abnormal sensor conditions. Low-power semiconductor technologies enable compact, battery-powered sensors suitable for wearable medical devices.

A key design trend in CGM development is the integration of wireless connectivity. Ultra-low-power wireless microcontrollers with Bluetooth® Low Energy connectivity allow readings to be transmitted continuously. Designers increasingly focus on extending sensor life, reducing power consumption and improving measurement accuracy. Power efficiency remains a critical design requirement because CGM devices typically operate continuously for up to two weeks before replacement. Rechargeable battery architectures are gaining popularity as manufacturers seek to reduce electronic waste and improve user convenience. The solution architecture typically combines electrochemical sensing, analog front-end processing, Bluetooth connectivity and battery management into a compact wearable platform.

Because CGMs are medical devices that directly influence patient treatment decisions, compliance with safety and regulatory standards is essential. Depending on the target market, systems commonly need to comply with FDA medical device requirements, IEC 60601 standards for medical electrical equipment, ISO 14971 for risk management and IEC 62304 for medical device software lifecycle processes. Wireless implementations must also satisfy Bluetooth and regional radio regulations.